Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
Northwestern University
mi
from
Chicago, IL
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
University of Chicago
mi
from
Chicago, IL
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
Norton Healthcare
mi
from
Louisville, KY
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
Norton Healthcare
mi
from
Louisville, KY
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
Oschner Baptist
mi
from
New Orleans, LA
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
Oschner Baptist
mi
from
New Orleans, LA
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
Saint John Hospital and Medical Center
mi
from
Detroit, MI
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
Saint John Hospital and Medical Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
University of Mississippi Medical Center
mi
from
Jackson, MS
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
Saint Louis University School of Medicine
mi
from
Saint Louis, MO
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
Saint Louis University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
Barnes Jewish Hospital
mi
from
St. Louis, MO
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
Barnes Jewish Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
Columbia University Medical Center
mi
from
New York, NY
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
Duke University
mi
from
Durham, NC
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
Tri-State Maternal Fetal Health
mi
from
Cincinnati, OH
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
Tri-State Maternal Fetal Health
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
Lehigh Valley Hospital
mi
from
Allentown, PA
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
Lehigh Valley Hospital
mi
from
Allentown, PA
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
Women and Infants Hospital
mi
from
Providence, RI
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
Women and Infants Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
Erlanger Medical Center
mi
from
Chattanooga, TN
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
Erlanger Medical Center
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
University of Texas Medical Branch
mi
from
Galveston, TX
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
University of Texas Medical Branch
mi
from
Galveston, TX
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
Baylor College of Medicine
mi
from
Houston, TX
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
University of Texas Houston School of Medicine
mi
from
Houston, TX
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
University of Texas Houston School of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
Intermontain Health
mi
from
Murray, UT
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
Intermontain Health
mi
from
Murray, UT
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
University of Utah Hospitals and Clinics
mi
from
Salt Lake City, UT
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
University of Utah Hospitals and Clinics
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated:  4/8/2016
Eastern Virginia Medical School
mi
from
Norfolk, VA
Pharmacokinetics, Safety and Efficacy Study of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia
Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1)
Status: Enrolling
Updated: 4/8/2016
Eastern Virginia Medical School
mi
from
Norfolk, VA
Click here to add this to my saved trials
Seattle-PAP Bubble Nasal CPAP and Work of Breathing
A Study to Evaluate the Efficacy of Seattle-PAP for the Respiratory Support of Premature Infants
Status: Enrolling
Updated:  4/12/2016
Texas Children's Hospital
mi
from
Houston, TX
Seattle-PAP Bubble Nasal CPAP and Work of Breathing
A Study to Evaluate the Efficacy of Seattle-PAP for the Respiratory Support of Premature Infants
Status: Enrolling
Updated: 4/12/2016
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  4/13/2016
Investigative Site #10
mi
from
Goodyear, AZ
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 4/13/2016
Investigative Site #10
mi
from
Goodyear, AZ
Click here to add this to my saved trials
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  4/13/2016
Investigative Site: #42
mi
from
Greenbrae, CA
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 4/13/2016
Investigative Site: #42
mi
from
Greenbrae, CA
Click here to add this to my saved trials
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  4/13/2016
Investigative Site: #39
mi
from
Denver, CO
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 4/13/2016
Investigative Site: #39
mi
from
Denver, CO
Click here to add this to my saved trials
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  4/13/2016
Investigative Site: #34
mi
from
Detroit, MI
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 4/13/2016
Investigative Site: #34
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  4/13/2016
Investigative Site: #34
mi
from
St. Louis, MO
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 4/13/2016
Investigative Site: #34
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  4/13/2016
Investigative Site: #36
mi
from
Las Vegas, NV
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 4/13/2016
Investigative Site: #36
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  4/13/2016
Investigative Site: # 37
mi
from
Oklahoma City, OK
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 4/13/2016
Investigative Site: # 37
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  4/13/2016
Investigative Site: # 33
mi
from
San Antonio, TX
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 4/13/2016
Investigative Site: # 33
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  4/13/2016
Investigative Site: #74
mi
from
Arkhangelsk,
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 4/13/2016
Investigative Site: #74
mi
from
Arkhangelsk,
Click here to add this to my saved trials
Comparison of Foley Balloon With or Without Traction for the Cervical Ripening
Comparison of Foley Balloon With or Without Traction for the Cervical Ripening
Status: Enrolling
Updated:  4/14/2016
St Luke's Hosptial & Health Network
mi
from
Bethlehem, PA
Comparison of Foley Balloon With or Without Traction for the Cervical Ripening
Comparison of Foley Balloon With or Without Traction for the Cervical Ripening
Status: Enrolling
Updated: 4/14/2016
St Luke's Hosptial & Health Network
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Duration of Use of Highly Effective Reversible Contraception
Real-world Duration of Use for Highly Effective Reversible Contraception (HERC): A Retrospective Review
Status: Enrolling
Updated:  4/15/2016
Clinical Research Facility
mi
from
Salt Lake, UT
Duration of Use of Highly Effective Reversible Contraception
Real-world Duration of Use for Highly Effective Reversible Contraception (HERC): A Retrospective Review
Status: Enrolling
Updated: 4/15/2016
Clinical Research Facility
mi
from
Salt Lake, UT
Click here to add this to my saved trials
Cardiovascular Health in Postpartum Women Diagnosed With Excessive Gestational Weight Gain
Cardiovascular Health in Postpartum Women Diagnosed With Excessive Gestational Weight Gain
Status: Enrolling
Updated:  4/18/2016
Stanford Hospital and Clinics
mi
from
Stanford, CA
Cardiovascular Health in Postpartum Women Diagnosed With Excessive Gestational Weight Gain
Cardiovascular Health in Postpartum Women Diagnosed With Excessive Gestational Weight Gain
Status: Enrolling
Updated: 4/18/2016
Stanford Hospital and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
Reading in Preterm and Full-term Children: Neural Basis and Prediction
Reading in Preterm and Full-term Children: Neural Basis and Prediction
Status: Enrolling
Updated:  4/19/2016
Stanford University
mi
from
Stanford, CA
Reading in Preterm and Full-term Children: Neural Basis and Prediction
Reading in Preterm and Full-term Children: Neural Basis and Prediction
Status: Enrolling
Updated: 4/19/2016
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated:  4/19/2016
Harbor UCLA Pediatrics
mi
from
Torrance, CA
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated: 4/19/2016
Harbor UCLA Pediatrics
mi
from
Torrance, CA
Click here to add this to my saved trials
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated:  4/19/2016
Children's National Health System
mi
from
Washington,
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated: 4/19/2016
Children's National Health System
mi
from
Washington,
Click here to add this to my saved trials
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated:  4/19/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated: 4/19/2016
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated:  4/19/2016
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated: 4/19/2016
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated:  4/19/2016
Hospital Universitario Austral
mi
from
Pilar,
Natural History Study of Children With Metachromatic Leukodystrophy
Natural History Study of Children With Metachromatic Leukodystrophy
Status: Enrolling
Updated: 4/19/2016
Hospital Universitario Austral
mi
from
Pilar,
Click here to add this to my saved trials
Mother-Infant Intervention for Postpartum Depression and Associated Mother-Infant Relationship Dysfunction
Dyadic Intervention for Women at Risk for Postpartum Depression and Their Infants
Status: Enrolling
Updated:  4/19/2016
MGH Insiitute of Health Professions
mi
from
Boston, MA
Mother-Infant Intervention for Postpartum Depression and Associated Mother-Infant Relationship Dysfunction
Dyadic Intervention for Women at Risk for Postpartum Depression and Their Infants
Status: Enrolling
Updated: 4/19/2016
MGH Insiitute of Health Professions
mi
from
Boston, MA
Click here to add this to my saved trials
Stereotactic Body Radiotherapy for Spine Tumors
Phase IV Trial Evaluating the Use of Stereotactic Body Radiotherapy for the Treatment of Spine Metastases and Primary Spine Tumors
Status: Enrolling
Updated:  4/20/2016
St. John's Mercy Medical Center
mi
from
St. Louis, MO
Stereotactic Body Radiotherapy for Spine Tumors
Phase IV Trial Evaluating the Use of Stereotactic Body Radiotherapy for the Treatment of Spine Metastases and Primary Spine Tumors
Status: Enrolling
Updated: 4/20/2016
St. John's Mercy Medical Center
mi
from
St. Louis, MO
Click here to add this to my saved trials
Insights Into Deep Brain Stimulation (DBS) for Cervical Dystonia
Pathophysiological Insights Into STN DBS for Primary Cervical Dystonia
Status: Enrolling
Updated:  4/21/2016
University of Florida
mi
from
Gainesville, FL
Insights Into Deep Brain Stimulation (DBS) for Cervical Dystonia
Pathophysiological Insights Into STN DBS for Primary Cervical Dystonia
Status: Enrolling
Updated: 4/21/2016
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Effects of Pioglitazone on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome (PCOS)
Determination if Indirectly Reducing Circulating Insulin by Improving Insulin Sensitivity With Pioglitazone Reduces Renal Clearance of D-chiro-inositol (DCI) Increases the Circulating Concentration of DCI and Enhances Insulin-stimulated Release of the D-chiro-inositol-containing Inositolphosphoglycan (DCI-IPG) Mediator in Obese Women With PCOS
Status: Enrolling
Updated:  5/2/2016
Virginia Commonwealth University General Clinical Research Center
mi
from
Richmond, VA
Effects of Pioglitazone on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome (PCOS)
Determination if Indirectly Reducing Circulating Insulin by Improving Insulin Sensitivity With Pioglitazone Reduces Renal Clearance of D-chiro-inositol (DCI) Increases the Circulating Concentration of DCI and Enhances Insulin-stimulated Release of the D-chiro-inositol-containing Inositolphosphoglycan (DCI-IPG) Mediator in Obese Women With PCOS
Status: Enrolling
Updated: 5/2/2016
Virginia Commonwealth University General Clinical Research Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Effects of Pioglitazone on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome (PCOS)
Determination if Indirectly Reducing Circulating Insulin by Improving Insulin Sensitivity With Pioglitazone Reduces Renal Clearance of D-chiro-inositol (DCI) Increases the Circulating Concentration of DCI and Enhances Insulin-stimulated Release of the D-chiro-inositol-containing Inositolphosphoglycan (DCI-IPG) Mediator in Obese Women With PCOS
Status: Enrolling
Updated:  5/2/2016
Hospital de Clinical Caracas
mi
from
Caracas,
Effects of Pioglitazone on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome (PCOS)
Determination if Indirectly Reducing Circulating Insulin by Improving Insulin Sensitivity With Pioglitazone Reduces Renal Clearance of D-chiro-inositol (DCI) Increases the Circulating Concentration of DCI and Enhances Insulin-stimulated Release of the D-chiro-inositol-containing Inositolphosphoglycan (DCI-IPG) Mediator in Obese Women With PCOS
Status: Enrolling
Updated: 5/2/2016
Hospital de Clinical Caracas
mi
from
Caracas,
Click here to add this to my saved trials
Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis
Metabolic and Endocrine Effects of Combination of Metformin and DPP4 Inhibitor Saxagliptin Compared to Saxagliptin or Metformin XR Monotherapy in Patients With PCOS and Impaired Glucose Regulation: A Single-blinded Randomized Pilot Study
Status: Enrolling
Updated:  5/5/2016
Woman's Hospital
mi
from
Baton Rouge, LA
Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis
Metabolic and Endocrine Effects of Combination of Metformin and DPP4 Inhibitor Saxagliptin Compared to Saxagliptin or Metformin XR Monotherapy in Patients With PCOS and Impaired Glucose Regulation: A Single-blinded Randomized Pilot Study
Status: Enrolling
Updated: 5/5/2016
Woman's Hospital
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Interventions to Reduce Excess Weight Gain in Pregnancy
Interventions to Reduce Excess Weight Gain in Pregnancy in Overweight and Obese Mothers
Status: Enrolling
Updated:  5/9/2016
Tufts Medical Center
mi
from
Boston, MA
Interventions to Reduce Excess Weight Gain in Pregnancy
Interventions to Reduce Excess Weight Gain in Pregnancy in Overweight and Obese Mothers
Status: Enrolling
Updated: 5/9/2016
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Interventions to Reduce Excess Weight Gain in Pregnancy
Interventions to Reduce Excess Weight Gain in Pregnancy in Overweight and Obese Mothers
Status: Enrolling
Updated:  5/9/2016
Tufts University Human Nutrition Research Center on Aging
mi
from
Boston, MA
Interventions to Reduce Excess Weight Gain in Pregnancy
Interventions to Reduce Excess Weight Gain in Pregnancy in Overweight and Obese Mothers
Status: Enrolling
Updated: 5/9/2016
Tufts University Human Nutrition Research Center on Aging
mi
from
Boston, MA
Click here to add this to my saved trials
Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)
Phase 1 Study of Topical Beta Blocker to Prevent the Proliferative Stage of Infantile Hemangioma
Status: Enrolling
Updated:  5/10/2016
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)
Phase 1 Study of Topical Beta Blocker to Prevent the Proliferative Stage of Infantile Hemangioma
Status: Enrolling
Updated: 5/10/2016
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials